Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmesol for Prevention of Marginal Ulcer After PPPD
NCT05551832Phase 3Unknown
- Sponsor
- Gangnam Severance Hospital
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in Marginal ulcer, sponsored by Gangnam Severance Hospital. Status: unknown.
02
Drugs
esomeprazole
03
Conditions
Marginal ulcer
Beyond the preview
Go deeper on NCT05551832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551832.